top of page
KRAS Cancer News & Updates
Sotorasib Provides Durable Clinical Benefit for Patients with NSCLC and KRAS Mutations
IASLC Exciting New Research to be Presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer’s...
Terri Conneran KRAS Kickers
Jan 25, 2021
The Improbable Targeted Therapy: KRAS as an Emerging Target in Non-Small Cell Lung Cancer
KRAS is a frequent oncogenic driver in solid tumors, including non-small cell lung cancer (NSCLC). It was previously thought to be an...
Terri Conneran KRAS Kickers
Jan 19, 2021
Overcoming Lung Cancer Stigma
Korin Miller She hid her diagnosis from her kids on Christmas Day: ' I didn’t want to ruin their Christmas' Terri Conneran had been...
Korin Miller
Dec 4, 2020
Kras Kickers at the 2020 National Lung Cancer Round Table
KRas Kickers will be attending the 2020 National Lung Cancer Roundtable to represent the 25% of the lung cancer patients with a Kirsten...
Terri Conneran KRAS Kickers
Feb 3, 2020
Honoring Jerry Cornelius of Canyon Creek. Family Man, Texan, Craftsman
https://www.kraskickers.org/post/honoring-jerry-cornelius-of-canyon-creek-family-man-texan-craftsman
Cancer Treatment & Clinical Trial Eligibility: What Patients Need to Know
Once you know your options, the next question is: Am I eligible? Here’s how doctors typically determine if a patient qualifies for a clinical trial or specific therapy—regardless of cancer type.
6 things that matter...
What Every Cancer Patient Should Know About Today’s Treatment Options
..just been diagnosed—or are navigating next step—you’re not alone. Cancer care has changed dramatically in the last decade. Today, you may have more treatment choices than ever before. This post is designed to help you understand your options and feel confident asking the right questions.
bottom of page